pembrolizumab
merck
['pembro', 'renal,(-adrenal)', 'kidney cancer', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', ' uc,(-ucsd),(-ucsf),']
kidney cancer research: subgroup analysis by ucla integrated staging system risk groups presented at asco #gu23 by 's further supports adjuvant pembrolizumab after nephrectomy as a standard of care in renal cell cancer. #kidneycancer cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090